Your browser doesn't support javascript.
loading
Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancers.
Hoshino, Isamu; Nabeya, Yoshihiro; Takiguchi, Nobuhiro; Gunji, Hisashi; Ishige, Fumitaka; Iwatate, Yosuke; Shiratori, Fumiaki; Yajima, Satoshi; Okada, Rei; Shimada, Hideaki.
Afiliação
  • Hoshino I; Division of Gastroenterological Surgery Chiba Cancer Center Chiba Japan.
  • Nabeya Y; Division of Gastroenterological Surgery Chiba Cancer Center Chiba Japan.
  • Takiguchi N; Division of Gastroenterological Surgery Chiba Cancer Center Chiba Japan.
  • Gunji H; Division of Gastroenterological Surgery Chiba Cancer Center Chiba Japan.
  • Ishige F; Department of Hepatobiliary and Pancreatic Surgery Chiba Cancer Center Chiba Japan.
  • Iwatate Y; Department of Hepatobiliary and Pancreatic Surgery Chiba Cancer Center Chiba Japan.
  • Shiratori F; Division of Gastroenterological Surgery Chiba Cancer Center Chiba Japan.
  • Yajima S; Department of Surgery School of Medicine Toho University Tokyo Japan.
  • Okada R; Department of Surgery School of Medicine Toho University Tokyo Japan.
  • Shimada H; Department of Surgery School of Medicine Toho University Tokyo Japan.
Ann Gastroenterol Surg ; 4(3): 275-282, 2020 May.
Article em En | MEDLINE | ID: mdl-32490341
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article